Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Differential survival and recurrence patterns of patients operated for breast cancer according to the new immunohistochemical classification: analytical survey from 1997 to 2012.
García Fernández A, Chabrera C, García Font M, Fraile M, Gónzalez S, Barco I, González C, Cirera L, Veloso E, Lain JM, Pessarrodona A, Giménez N. García Fernández A, et al. Among authors: cirera l. Tumour Biol. 2013 Aug;34(4):2349-55. doi: 10.1007/s13277-013-0782-3. Epub 2013 Apr 19. Tumour Biol. 2013. PMID: 23605321
Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
García-Fernández A, Lain JM, Chabrera C, García Font M, Fraile M, Barco I, Torras M, Reñe A, González S, González C, Piqueras M, Veloso E, Cirera L, Pessarrodona A, Giménez N. García-Fernández A, et al. Among authors: cirera l. Breast J. 2015 Sep-Oct;21(5):533-7. doi: 10.1111/tbj.12455. Epub 2015 Jul 17. Breast J. 2015. PMID: 26190560
Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. a single institution survey spanning 1998 to 2010.
García Fernández A, Giménez N, Fraile M, González S, Chabrera C, Torras M, González C, Salas A, Barco I, Cirera L, Cambra MJ, Veloso E, Pessarrodona A. García Fernández A, et al. Among authors: cirera l. Breast. 2012 Jun;21(3):366-73. doi: 10.1016/j.breast.2012.03.004. Epub 2012 Apr 7. Breast. 2012. PMID: 22487206 Free article.
Differential patterns of recurrence and specific survival between luminal A and luminal B breast cancer according to recent changes in the 2013 St Gallen immunohistochemical classification.
García Fernández A, Chabrera C, García Font M, Fraile M, Lain JM, Gónzalez S, Barco I, González C, Torres J, Piqueras M, Cirera L, Veloso E, Pessarrodona A, Giménez N. García Fernández A, et al. Among authors: cirera l. Clin Transl Oncol. 2015 Mar;17(3):238-46. doi: 10.1007/s12094-014-1220-8. Epub 2014 Oct 1. Clin Transl Oncol. 2015. PMID: 25270605
A study comparing two consecutive historical periods in breast cancer with a focus on surgical treatment, loco-regional recurrence, distant metastases and mortality.
García-Fernández A, Chabrera C, García-Font M, Fraile M, Barco I, González S, Cirera L, Lain JM, González C, Veloso E, Codina L, Piqueras M, Pessarrodona A, Gimenez N. García-Fernández A, et al. Among authors: cirera l. Clin Transl Oncol. 2015 Apr;17(4):296-305. doi: 10.1007/s12094-014-1227-1. Epub 2014 Oct 1. Clin Transl Oncol. 2015. PMID: 25270606
Use of axillary ultrasound, ultrasound-fine needle aspiration biopsy and magnetic resonance imaging in the preoperative triage of breast cancer patients considered for sentinel node biopsy.
García Fernández A, Fraile M, Giménez N, Reñe A, Torras M, Canales L, Torres J, Barco I, González S, Veloso E, González C, Cirera L, Pessarrodona A. García Fernández A, et al. Among authors: cirera l. Ultrasound Med Biol. 2011 Jan;37(1):16-22. doi: 10.1016/j.ultrasmedbio.2010.10.011. Ultrasound Med Biol. 2011. PMID: 21144955
The appropriate axillary procedure after a positive sentinel node in breast cancer patients: the "Hôpital Tenon" score revisited. A two-institution study.
Barco I, García-Fernández A, Chabrera C, Fraile M, Vallejo E, Lain JM, Deu J, González S, González C, Veloso E, Torres J, Torras M, Cirera L, Pessarrodona A, Giménez N, García-Font M. Barco I, et al. Among authors: cirera l. Clin Transl Oncol. 2016 Nov;18(11):1098-1105. doi: 10.1007/s12094-016-1487-z. Epub 2016 Feb 26. Clin Transl Oncol. 2016. PMID: 26920150
Are breast cancer patients treated with radiotherapy younger now than ten years ago?
Bonet M, Godoy P, Cambra MJ, Mur E, Algara M, Fernandez L, Dalmau E, Arcusa À, Seguí MÀ, Saigí E, Gonzalez S, Cirera L, Solé JM. Bonet M, et al. Among authors: cirera l. Rep Pract Oncol Radiother. 2014 Jul 17;20(1):22-6. doi: 10.1016/j.rpor.2014.05.003. eCollection 2015 Jan. Rep Pract Oncol Radiother. 2014. PMID: 25535580 Free PMC article.
Nonpegylated liposomal doxorubicin (TLC-D99), paclitaxel, and trastuzumab in HER-2-overexpressing breast cancer: a multicenter phase I/II study.
Cortes J, Di Cosimo S, Climent MA, Cortés-Funes H, Lluch A, Gascón P, Mayordomo JI, Gil M, Benavides M, Cirera L, Ojeda B, Rodríguez CA, Trigo JM, Vazquez J, Regueiro P, Dorado JF, Baselga J; Spanish Breast Cancer Cooperative Group SOLTI. Cortes J, et al. Among authors: cirera l. Clin Cancer Res. 2009 Jan 1;15(1):307-14. doi: 10.1158/1078-0432.CCR-08-1113. Clin Cancer Res. 2009. PMID: 19118059 Clinical Trial.
101 results